InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

- Current share price for BDX : $0.060

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$22 Proposed issue of securities - BDX 29 Aug 2023 10:05AM $0.100 $0.060 fallen by 40%
$22 $2.4m Capital Raise to Further BREASTEST Commercialisation 28 Aug 2023 8:50AM $0.115 $0.060 fallen by 47.83%
$22 BCAL Presentation August 2023 24 Aug 2023 2:56PM $0.115 $0.060 fallen by 47.83%
$22 Trading Halt 24 Aug 2023 9:43AM $0.115 $0.060 fallen by 47.83%
$22 Application for quotation of securities - BDX 11 Aug 2023 6:41PM $0.130 $0.060 fallen by 53.85%
$22 Notification of cessation of securities - BDX 11 Aug 2023 6:41PM $0.130 $0.060 fallen by 53.85%
$22 Application for quotation of securities - BDX 10 Aug 2023 8:55AM $0.140 $0.060 fallen by 57.14%
$22 BCAL Investor Education Update & Webinar 8 Aug 2023 9:56AM $0.145 $0.060 fallen by 58.62%
$22 Breakthrough Results a Major Step Towards Commercialisation 2 Aug 2023 8:28AM $0.080 $0.060 fallen by 25%
$22 Application for quotation of securities - BDX 28 Jul 2023 6:57PM $0.070 $0.060 fallen by 14.29%
$22 Shares and Options Released from Escrow 28 Jul 2023 6:56PM $0.070 $0.060 fallen by 14.29%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2023 8:36AM $0.070 $0.060 fallen by 14.29%
$22 Shareholder Newsletter 20 Jul 2023 9:16AM $0.070 $0.060 fallen by 14.29%
$22 Notification regarding unquoted securities - BDX 30 Jun 2023 8:41AM $0.070 $0.060 fallen by 14.29%
$22 Proposed issue of securities - BDX 30 Jun 2023 8:34AM $0.070 $0.060 fallen by 14.29%
$22 BCAL Findings Presented at ASCO Annual Meeting 6 Jun 2023 12:14PM $0.100 $0.060 fallen by 40%
$22 BCAL Appoints David Darling as Advisor 16 May 2023 8:17AM $0.087 $0.060 fallen by 31.03%
$22 Notification regarding unquoted securities - BDX 11 May 2023 8:43AM $0.090 $0.060 fallen by 33.33%
$22 Change of Director's Interest Notice 3 May 2023 6:52PM $0.086 $0.060 fallen by 30.23%
$22 BCAL Opens Development & Clinical Service Laboratory 3 May 2023 12:36PM $0.087 $0.060 fallen by 31.03%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 24 Apr 2023 11:18AM $0.075 $0.060 fallen by 20%
$22 Half Yearly Report and Accounts 23 Feb 2023 5:30PM $0.062 $0.060 fallen by 3.23%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 16 Jan 2023 9:07AM $0.060 $0.060 fallen by 0%
$22 Results of Meeting 1 Dec 2022 7:42PM $0.059 $0.060 risen by 1.69%
$22 Results of Meeting 29 Nov 2022 5:17PM $0.059 $0.060 risen by 1.69%

201 - 225 of 292 results

Page 9 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.